Southridge Partners II enters into $10 million equity purchase agreement with TechniScan for clinical studies of emerging breast cancer diagnostic technology
January 28, 2011
RIDGEFIELD, CT – Stephen Hicks, Chairman and CEO of Southridge, LLC (“Southridge”), today announced that Southridge Partners II, an institutional investor, has entered into a $10 million equity purchase agreement with TechniScan, Inc. (OTC BB: TSNI), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system.
We are excited to be TechniScan’s equity investor in this major phase of developing better breast cancer diagnostics,” said Mr. Hicks. “Southridge is committed to working with TechniScan in the vital research of this emerging technology.”
Pursuant to a purchase agreement, TechniScan has the right, at its discretion, to sell to Southridge up to $10 million of its common stock over a 24-month period. The Company will have the right, but is not obligated, to sell stock to Southridge depending on certain conditions as set forth in the purchase agreement.
“We are pleased to have secured this equity agreement with Southridge, a forward thinking institutional investor that provides future flexibility in capital raising,” said Dave Robinson, chief executive officer of TechniScan. “We plan to use the proceeds, as needed from the agreement, to support our clinical studies of Warm Bath Ultrasound breast imaging technology.”
About Southridge, LLC
Southridge LLC is a diversified financial holding company offering a wide range of products and services, including Fund Management, Investment Banking, Merchant Banking, Wealth Management and Business Solutions.
About TechniScan
TechniScan, Inc. is a medical device company engaged in the development and commercialization of a non-invasive imaging tool designed to provide physicians with automated ultrasound images of the human breast. TechniScan’s WBU(TM) imaging device is limited by U.S. law to investigational use unless, and until, cleared by the FDA. For more information, please visit www.tsni.com.
Southridge Partners II Enters into an Equity Purchase Agreement with Monkey Rock Group, INC.
RIDGEFIELD, CT, November 2, 2010, Monkey Rock Group, Inc. (OTCBB – MKRO) has
announced it has agreed to an equity purchase agreement (EPA) with Southridge Partners II
LLC (“Southridge”) in the amount of $10,000,000, which will be used for working capital.
Monkey Rock Group, Inc. (www.monkeyrockusa.com), founded in 2009, Sturgis, SD-based,
is a retail leisure brand positioned to service the greater North American motorcycle rally
industry. Currently, the Company has retail business operations in the short-cycle food,
beverage and entertainment industry.
The Company’s foundation is built upon a professional European-styled leisure concept that
serves select North American markets with its unique delivery of food, beverage and live adultthemed
entertainment venues. The concept is a travelling one, where the Company’s goal is to
serve some of the country’s largest social and sporting events to include motorcycle and auto
rallies, rodeo events and auto races.
About Southridge LLC
Southridge LLC is a diversified financial holding company offering a wide range of products and
services, including Fund Management, Investment Banking, Merchant Banking, Wealth
Management and Business Solutions. For more information please visit www.southridgellc.com
Southridge Partners II Enters into an Equity Purchase Agreement with Curaxis Pharmaceutical Corporation for Clinical Alzheimer’s Disease Trials
RIDGEFIELD, CT, September 27, 2010– Stephen Hicks, Chairman and CEO, of
Southridge LLC (“Southridge”), and Patrick S. Smith, President and Chief Executive Officer of
Curaxis Pharmaceutical Corp (CURX.OB) at www.curaxispharma.com, jointly announced a $25
million equity purchase agreement with Southridge Partners II, LP, an institutional investor.
“We are excited to be Curaxis’ Equity Investor in this new phase of the Company’s development.
Southridge is committed to working with Curaxis in this vital research toward an Alzheimer’s
disease treatment,” said Mr. Hicks.
Pursuant to a purchase agreement, the Company has the right, at its discretion, to sell to
Southridge up to $25 million of its common stock from time to time over a thirty-six month
period. Curaxis will have the right, but is not obligated to, sell stock to Southridge depending on
certain conditions as set forth in the purchase agreement.
“We are pleased to have secured this equity agreement with Southridge, a forward thinking
institutional investor which provides future flexibility in capital raising and are thrilled to have
the continued support of Southridge,” said Patrick Smith. “We plan to use proceeds, as needed
from the agreement, to support our upcoming Phase IIb trial in women of our Alzheimer’s
disease candidate, Memryte.
About Southridge LLC
Southridge LLC is a diversified financial holding company offering a wide range of products and
services, including Fund Management, Investment Banking, Merchant Banking, Wealth
Management and Business Solutions. For more information please visit www.southridgellc.com
CNNMoney.com – Tech stock rally seen at the open
New York (CNNMoney.com) – Better-than-expected earnings from Oracle and Research in Motion were expected to lift U.S. stocks, particularly the tech sector, at Friday’s open…
http://www.southridgellc.com/news/fin_services/20100917_CNNMoney.pdf
Brian Bolan, Founder of Bolan’s Bytes Joins Southridge Independent Research Group
Ridgefield, CT, New York, NY — August 10, 2010 Southridge Research Group is pleased to
welcome Brian Bolan, the founder and senior analyst of Bolan’s Bytes, to its recently established
full service, independent, institutional research platform.
Prior to joining Southridge Research Group, Mr. Bolan worked at a number of boutique research
shops while based in Chicago during the last eleven years. Brian has over 14 years of financial
experience, having spent more than a decade as a sell-side research analyst. As the Director of
Research for Jackson Securities, Brian worked hand in hand with a three person research team
and three person trading team, which earned numerous merit awards. In a LeBron Jamesesque
statement, Mr. Bolan said, “…this Fall, I’m going to take my talents to Southridge
Research Group and join their team.” Bolan went on to say that he will continue his Internet
coverage and his practice of helping clients be proactive by utilizing his unique perspective.
Brian started his career with NatCity Investments, Inc., where he worked in the corporate
finance division of their investment banking department. He got his start in research covering
technology and early dot com names. Brian received his degree from Cleveland State University
and holds FINRA Series 7, 24, 63, 86 and 87 licenses.
Jack Murphy, Managing Director at Southridge has stated, “Brian has done a great job
everywhere he has been and I expect this to continue. His sell-side experience and high quality
work make him an ideal fit within our research platform.”
About Southridge Research Group (“SRG”)
Southridge Research Group is an independent provider of proprietary equity research for
institutional clients. For more information please visit www.southridgeresearch.com or,
contact: Jack Murphy, Managing Director, at 203 702 1864 or email jmurphy@southridgegroup.com.
About Southridge Investment Group (“SIG”)
Southridge Investment Group LLC is a full service registered broker-dealer and investment
banking firm. The investment banking practice focuses on the sponsorship needs of small,
medium and emerging growth companies as well as the needs of both institutional and
individual investors interested in that segment of the market. The firm offers a full range of
corporate finance services, including underwritings, M & A, financial advisory, valuations and
private placements. For more information on Southridge Investment Group LLC please visit
www.southridgegroup.com.
About Southridge LLC
Southridge LLC is a diversified financial holding company offering a wide range of products and
services, including Fund Management, Investment Banking, Merchant Banking, Wealth
Management and Business Solutions. For more information please visit www.southridgellc.com.
